SCHEMBL3882928

SCHEMBL3882928

CCOC(=O)CCc1ccc(OCC2CCCCC2)c(-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
P2RY12 Q9H244 1/20 0.38
S1PR1 P21453 1/20 0.38
XDH P47989 3/20 0.38
ENPP2 Q13822 1/20 0.38
ACHE P22303 1/20 0.37
HTR4 Q13639 1/20 0.37
C5AR1 P21730 1/20 0.37
MTOR P42345 1/20 0.37
CHRNA7 P36544 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
SYK P43405 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
P2RX3 P56373 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3883830 0.90 MEN1 (0.40) HRH3S1PR1ENPP2ACHEHTR4
SCHEMBL3882037 0.88 THRA (0.48) S1PR1XDHENPP2ACHEHTR4
SCHEMBL3881187 0.87 THRA (0.47) S1PR1XDHENPP2ACHEHTR4
SCHEMBL3888471 0.86 ADRB2 (0.44) CCNCCDK8HRH3S1PR1XDH
SCHEMBL3882775 0.85 ELANE (0.42) HRH3S1PR1C5AR1MEN1KMT2A
SCHEMBL3883011 0.85 HDAC1 (0.39) HRH3PDE3BPDE3AP2RY12ENPP2
SCHEMBL8984887 0.85 CYP4F2 (0.46) HRH3S1PR1C5AR1THRATHRB
SCHEMBL3884978 0.85 MEN1 (0.42) HRH3S1PR1XDHC5AR1MTOR
SCHEMBL3888457 0.84 FFAR4 (0.42) S1PR1XDHENPP2ACHEHTR4
SCHEMBL3882703 0.82 HRH3 (0.43) HRH3PDE3BPDE3AP2RY12S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 CCNC 2174/4885CDK8 3600/4885HRH3 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.